Immediate Impact
4 by Nobel laureates 21 from Science/Nature 66 standout
Citing Papers
Designing antibodies as therapeutics
2022 Standout
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
2020 Standout
Works of David W. Meyer being referenced
SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
2013
Design, Synthesis, and Biological Evaluation of Antibody−Drug Conjugates Comprised of Potent Camptothecin Analogues
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David W. Meyer | 430 | 328 | 359 | 16 | 761 | |
| Lydia Armstrong | 302 | 99 | 639 | 19 | 952 | |
| Stephen I. Rudnick | 261 | 355 | 388 | 11 | 783 | |
| Darin Smith | 317 | 82 | 697 | 13 | 970 | |
| Alexander Zheleznyak | 292 | 302 | 348 | 26 | 927 | |
| Carmela Kantor | 220 | 190 | 407 | 13 | 872 | |
| David Kan | 321 | 304 | 364 | 21 | 791 | |
| W J Rettig | 355 | 166 | 465 | 19 | 951 | |
| Véronique Blanc | 382 | 263 | 296 | 19 | 715 | |
| Shuichi Ikeyama | 268 | 112 | 544 | 13 | 889 | |
| Oren Dwir | 120 | 120 | 356 | 17 | 900 |
All Works
Login with ORCID to disown or claim papers
Loading papers...